A delegation from the China Association of In Vitro Diagnostics (CAIVD), the China Professional Community of Experimental Medicine (CPCEM), and CACLP visited Incheon for a four-day industry and academic exchange program.

Following its announcement to return to Xiamen in 2026, CACLP has received overwhelming enthusiasm from exhibitors worldwide. As of October 2025, more than 1,000 companies have confirmed their participation for next year’s event, reaffirming CACLP’s role as the world‘s largest IVD event and an important annual gathering of the global diagnostic community.

Company: Liming Website: www.limingbio.com Product: StrongStep® Trichomonas/ Candida Combo

Company: Liming Website: www.limingbio.com Product: StrongStep® Chlamydia trachomatis/ Neisseria gonorrhoeae Combo

Company: Landwind Website: www.landwind.com.cn Product: LW D6580

Company: Landwind Website: /uploads/allimg/180628/1ZU42P3-0.jpg Product: LW C400

The Name of Devices and Model, Name and Address of Manufacture must be unanimously the same as the contents carried in the documents approved by the government of the Country (Region) of Origin, and must be consistent with the contents concerned c

In order to implement the Medical Device Supervision and Management Ordinance (State Council Decree No. 650) and the Opinion of the State Council on the reform of drug and medical device review and approval system (Guo Fa [2015] 44), and to

In order to implement the Opinions of the State Council on the Reform of Examination and Approval System for Medicine and Medical Devices (Guo Fa [2015] No. 44) and the reform spirit of relevant administrative examination and approval syste

A.TheDirectionfortheApplicationFormofRegistration 1.AllthecontentsfilledinshallbeinbothChineseandEnglish； 2.Upontheapplication,theformshallbeprinted； 3.Alltheitemsmustbecompletelyfilledin,andasforthevacantitems,ldquo;/rdquo;shallbeusedt

China Food and Drug Administration (CFDA) recently released the 2014 Drug Review Annual Report. The Annual Report describes the general situation of drug registration acceptance, review and approval in 2014, and analyzes the data of accepta

A. The Direction for the Application Form of Registration 1.All the contents filled in shall be in both Chinese and English； 2.Upon the application, the form shall be printed ；